Abbott: Abbott's AVEIR Feasibility Study Shows Promising Safety And Performance For Leadless Pacemaker Tech
(RTTNews) - Abbott (ABT) announced data from the AVEIR Conduction System Pacing acute clinical feasibility study, which demonstrated the safety and performance of the investigational AVEIR Conduction System Pacing leadless pacemaker technology.
Read full article »
Chairman & CEO
Robert B. Ford
Abbott is an Illinois-based healthcare company that develops and markets medical devices in fields such as neuroscience and diabetes.
Read more